Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Paolo Tarantino
Nov 29, 2023, 16:26 |
Blog
Top 10 abstracts to keep an eye on for SABCS 23 by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "10 days to…
Nov 27, 2023, 17:43 |
Blog
Paolo Tarantino: Can we get rid of the anthracyclines from the KN522 regimen?
Paolo Tarantino, Researcher at the European Institute of Oncology and clinical research fellow at the…
Nov 19, 2023, 17:20 |
Drugs
Paolo Tarantino: More important than ever to perform NGS/ctDNA to select the best 2L treatment after CDK4/6i
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: “Capivasertib is now…
Nov 11, 2023, 17:08 |
Blog
Katsuaki Maehara: Great article about ADCs by Paolo Tarantino
Katsuaki Maehara, Director of Medical Education Colleagues, recently shared the following on X/Twitter: "Great article…
Nov 6, 2023, 04:03 |
Blog
Paolo Tarantino: Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "Trastuzumab Deruxtecan (T-DXd)…
Nov 2, 2023, 09:32 |
Dialogues
5min OncoDaily Updates with Chandler Park: Paolo Tarantino on the future of triple negative breast cancer with the IMPRESSIVE phase Ib/II BEGONIA study
[embed]https://www.youtube.com/watch?v=vSQg9swI61A&t=7s[/embed]
Oct 20, 2023, 20:02 |
Insight
10 ESMO23 breast cancer abstracts not to miss by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on Twitter: "ESMO23 will have…
Oct 19, 2023, 18:39 |
Blog
Paolo Tarantino: The BEGONIA ph1/2 trial ages like good wine
Quoting Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, on X/Twitter: “The BEGONIA ph1/2 trial…
Oct 16, 2023, 23:06 |
Opinion
Paolo Tarantino: Greatly enjoyed contributing to the ADC session at Targets23!
Paolo Tarantino, MD and Researcher at the European Institute of Oncology and Clinical Research Fellow at…
Oct 14, 2023, 22:16 |
Blog
Paolo Tarantino: So much going on in the ADC field.
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared the following on Twitter: "So…
11
12
13
14
15
All:
196
Posts:
121 - 130
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube